This article was revised on July 1, 2021, to update the content and coverage effective dates. To learn about testing for COVID-19, please read this article. To learn about billing and coding for COVID-19 testing, please read this article.
Member coverage for COVID-19 treatment
Depending on the member’s plan, the effective dates for coverage of COVID-19 treatment is as follows:
- Commercial members: March 6, 2020, through October 31, 2021;
- Medicare Supplement and Keystone CHIP members: March 6, 2020, through the end of the public health emergency;
- Medicare Advantage members: through the end of the public health emergency.
Subject to the effective dates noted above, Independence will cover the treatment of COVID-19 as follows:
- Independence will waive cost-sharing for in-network, inpatient, acute care treatment of members diagnosed with COVID-19, whether for medical or behavioral health.
- For Medicare Advantage members, as part of the filed benefits for Medicare Advantage business in 2021, there is no cost-sharing for in-network inpatient acute care treatment associated with COVID-19.
- Independence will waive cost-sharing for emergency department visits associated with admissions for in-network, in-patient, acute care treatment of COVID-19 whether for medical or behavioral health. For Medicare Advantage members, cost-sharing for emergency department visits will be waived through the
end of the public health emergency.
- CHIP standard coverage includes no member cost sharing for in-network, inpatient acute care treatment whether COVID-19 or not.
- CHIP standard coverage waives emergency department visit copays for admissions whether COVID-19 or not.
For services not related to COVID-19, we will continue to apply the appropriate member cost-sharing.
This includes members enrolled in our fully insured commercial, Keystone CHIP, and Medicare Advantage plans, and the individual and family plans available through the Affordable Care Act.
Note: Self-funded customers can opt out of waiving cost-sharing for the treatment of COVID-19.
Independence will reimburse in-network health care providers for the treatment of COVID-19 as outlined above at their contracted rates including the member cost-share amount.
Approved drugs to treat patients
Independence will cover the use of approved drugs for the treatment of Commercial and Medicare Advantage patients who have been diagnosed with COVID-19. Read the full
article to learn more.
Independence is committed to providing our members with access to the care they need during the COVID-19 pandemic. We encourage all Independence members and providers to visit our dedicated COVID-19 webpage regularly for the latest news and updates. We will continue to evaluate member needs as the situation changes.
Read more about coverage of services related to COVID-19 in the News Articles posted on our Medical and Claim Payment Policy Portal: